Meeting of Scientific Advisory Board.
December 5, 1999

---

Proneuron's Scientific Advisory Board held a highly successful meeting to appraise current progress and discuss future directions. This meeting provided an opportunity for the company to subject itself to the critical appraisal of eminent clinicians and scientists. Results from the company's research projects and development work were presented, along with a description of the upcoming clinical trials of macrophage therapy for complete spinal cord injury. Prof. Charles Tator and Prof. Edward Benzel both gave presentations about spinal cord injury clinical assessment and treatment strategies. Prof. Paul Kaufman presented an overview of glaucoma etiology and treatment. The session also included some very informative and constructive discussions. The meeting was an extremely worthwhile event, of great value to Proneuron's development and standing as a biotechnology company, and a significant boost to the company's confidence.